Navigation Links
Exagen Launches New Diagnostic Assays for Bowel Disease at Digestive Disease Week Conference
Date:5/28/2009

Company signs partnership agreement with Clinical Reference Laboratory

ALBUQUERQUE, N.M., May 28 /PRNewswire/ -- Exagen Diagnostics, Inc. today announced the availability of two new genomic blood tests to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Exagen will present the tests at Digestive Disease Week 2009 in Chicago, May 30 - June 4, booth #2429.

The eXaIBStest identifies patients with IBS, while the eXaIBD test identifies patients with IBD. Compared with other available laboratory tests, Exagen's assays produce significantly more accurate test results, providing physicians with more reliable data to aid in diagnosing their patients. The tests were invented using Coperna(TM), Exagen's proprietary genomic data mining software.

"Until now, physicians have relied on a wide range of tests and procedures to aid in the diagnosis of IBS and IBD, including blood tests with limited diagnostic performance," said Exagen President and CEO John Alsobrook, Ph.D. "Approximately 30 million people in the United States suffer from these diseases. Exagen's tests offer physicians several distinct diagnostic advantages, such as increased sensitivity, and we are pleased to make them readily available."

Exagen's tests are RNA-based, and require a single tube of peripheral blood. To support the front-end specimen handling and logistics, Exagen has signed a partnership agreement with Lenexa, Kansas-based Clinical Reference Laboratory (CRL), one of the nation's largest privately held clinical laboratories. This partnership enables Exagen to significantly expand its testing capacity.

"Exagen Diagnostics has developed an extremely promising series of diagnostic assays for gastrointestinal diseases," said Heather Newkirk, Ph.D., CLSp (MB), Executive Director of Molecular Diagnostics at CRL. "We welcome the opportunity to partner with them in bringing these important tests to the physician community."

About Exagen Diagnostics, Inc.

Exagen Diagnostics is a CLIA-registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. For more information, visit www.exagen.com.

About Clinical Reference Laboratory, Inc (CRL Global Services)

Established in 1979, CRL Global Services is a privately held reference laboratory in Lenexa, Kansas offering leading-edge testing services in the areas of Clinical Trials, Molecular Diagnostics, Insurance, and Toxicology. CRL is one of the largest single-site laboratories in the country and analyzes over 80 million tests annually. Additional information is available at www.crlcorp.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
2. Quick Medical Launches Medical Equipment Lease Program
3. Snoring Isn't Sexy Launches Public Awareness Campaign
4. Gyminee Raises 525K and Relaunches as DailyBurn
5. Trusted Translations Launches "Translation for St. Jude" Initiative at St. Jude Gala in New York
6. Mayo Clinic Launches Medical Science Blog
7. Transplant Expo Launches in Boston to Educate About Miracle of Transplantation and Address Organ Donor Shortage
8. National Safety Council Launches June National Safety Month With Free Training
9. PHSI Launches New Websites to Promote Sustainable Eco-Friendly Bottle-less Drinking Water Technology
10. Four Rivers Software System Launches TMS OnSite Professional
11. Health and Wellness Partners, Inc., A Wholly Owned Subsidiary of Zealous Inc., Launches Organix+
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER ... Mercy Medical Center will serve as the official title sponsor of the Baltimore Women’s ... 25, 2017, thousands of women will walk or run the course around the Baltimore ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy Network, a ... at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben ... the visionary leader in the training of physicians, scientists, and members of the ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without a ... compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market Size & Forecast By Type (Insource IONM, Outsource IONM), ... report to their offering. ... The global Intraoperative Neuromonitoring (IONM) market ... intraoperative neuromonitoring market is anticipated to witness significant growth in ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets ... Market 2017-2021" report to their offering. ... The global energy-based aesthetic devices market ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, ... from industry experts. The report covers the market landscape and its ...
(Date:3/29/2017)... SAN DIEGO , March 29, 2017 Avelas Biosciences, ... care from diagnosis through treatment, today announced that Carmine N. ... of the company at the Needham & Company 16 th ... EDT (8:20 a.m. PDT) at the Westin Grand Central Hotel in ... Biosciences ...
Breaking Medicine Technology: